Erlonat is useful in the effective treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. erlotinib 150 mg Hydrochloride is the active ingredient involved in the composition of this regimen. This medicine is manufactured by NATCO pharma. This regimen is available in two strengths; i.e 100 mg and 150 mg.

Erlonat is useful in the effective treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. erlotinib 150 mg Hydrochloride is the active ingredient involved in the composition of this regimen. This medicine is manufactured by NATCO pharma. This regimen is available in two strengths; i.e 100 mg and 150 mg.